Scarica l'app Stockscreener
23.17
0.30%
0.07
Dopo l'orario di chiusura:
23.30
0.13
+0.56%
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Earnings Beat: How Zymeworks Inc stock reacts to oil pricesJuly 2025 Analyst Calls & Safe Entry Trade Signal Reports - moha.gov.vn
Can Zymeworks Inc. stock hit analyst price targets2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - ulpravda.ru
How Zymeworks Inc. stock reacts to oil pricesShare Buyback & Weekly Stock Performance Updates - ulpravda.ru
Zymeworks (ZYME) Is Down 5.6% After Positive Phase 3 Ziihera Data Unlocks US$440 Million Milestones - simplywall.st
Will Zymeworks Inc. stock benefit from upcoming earnings reportsTrend Following Strategies & Affordable Trading Plans - ulpravda.ru
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial - Benzinga
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial - Sahm
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Zymeworks’ Ziihera Sets New Survival Benchmark in First-Line HER2-Positive Gastric Cancer Trial - TipRanks
Zymeworks Reports Positive Phase 3 HERIZON-GEA-01 Results for Ziihera as Potential New Standard of Care in HER2-Positive First-Line Metastatic GEA - Quiver Quantitative
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - GlobeNewswire
Paul Andrew Moore Sells 20,110 Shares of Zymeworks (NYSE:ZYME) Stock - MarketBeat
Jeffrey Smith Sells 10,538 Shares of Zymeworks (NYSE:ZYME) Stock - MarketBeat
Insider Selling: Zymeworks (NYSE:ZYME) CEO Sells 54,343 Shares of Stock - MarketBeat
Zymeworks (NASDAQ:ZYME) Stock Price Down 6.8%What's Next? - MarketBeat
Zymeworks (NYSE:ZYME) Stock Price Down 6.1%Should You Sell? - MarketBeat
Zymeworks (ZYME): Biotech under pressure as investors wait for the next catalyst - AD HOC NEWS
Zymeworks Inc: Can ZYME’s Quiet Rally Turn Into a Breakout Story? - AD HOC NEWS
Zymeworks shareholders back directors, executive pay and auditor - MSN
Zymeworks shareholders elect directors and approve compensation at annual meeting - Investing.com
Zymeworks Shareholders Back Directors, Executive Pay and Auditor - TipRanks
Short Interest in Zymeworks Inc. (NASDAQ:ZYME) Drops By 29.8% - MarketBeat
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adeno - Macau Business
Zymeworks Announces Participation in Upcoming Investor Conferences - Macau Business
Kenneth Galbraith Sells 47,528 Shares of Zymeworks (NYSE:ZYME) Stock - MarketBeat
Zymeworks Insider Sold Shares Worth $1,284,311, According to a Recent SEC Filing - marketscreener.com
Is Zymeworks Inc. stock vulnerable to regulatory risksBull Run & Daily Chart Pattern Signal Reports - Улправда
How rising interest rates impact Zymeworks Inc. stockIndex Update & AI Based Buy/Sell Signal Reports - ulpravda.ru
Zymeworks Inc. $ZYME Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Aug Fed Impact: How rising interest rates impact Zymeworks Inc. stockTrade Entry Report & Expert-Curated Trade Recommendations - Улправда
Why retail investors pile into Zymeworks Inc. stock2025 Winners & Losers & Low Drawdown Investment Strategies - DonanımHaber
Is Zymeworks Inc. (NASDAQ:ZYME) Trading At A 50% Discount? - Yahoo Finance
Zymeworks Inc. $ZYME Shares Acquired by Squarepoint Ops LLC - MarketBeat
Zymeworks Inc. (NASDAQ:ZYME) Receives Average Rating of "Buy" from Analysts - MarketBeat
How institutional buying supports Zymeworks Inc. stockPortfolio Gains Report & Community Verified Swing Trade Signals - ulpravda.ru
Free cash flow per share of Zymeworks Inc. – TRADEGATE:ZA8 - TradingView — Track All Markets
Buy Signal: How rising interest rates impact Zymeworks Inc. stockMarket Activity Recap & Trade Opportunity Analysis - Улправда
Will Zymeworks Inc. (ZA8) stock return to pre crash levelsJuly 2025 PreEarnings & Smart Money Movement Alerts - Улправда
Truist Initiates Zymeworks at Buy With $40 Price Target - marketscreener.com
Zymeworks (NYSE:ZYME) Earns Buy Rating from Analysts at Truist Financial - MarketBeat
Zymeworks (NASDAQ:ZYME) Stock Rating Upgraded by Wells Fargo & Company - MarketBeat
Zymeworks (NYSE:ZYME) Shares Gap UpWhat's Next? - MarketBeat
Zymeworks (NASDAQ:ZYME) Shares Gap UpHere's What Happened - MarketBeat
EcoR1 Capital LLC Increases Stake in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. (NYSE:ZYME) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Wells Fargo Upgrades Zymeworks (ZYME) - Nasdaq
Zymeworks (ZYME) Receives Rating Upgrade and Increased Price Tar - GuruFocus
Redmile Group LLC Sells 638,318 Shares of Zymeworks Inc. $ZYME - MarketBeat
Could Zymeworks' blockbuster drug success revive Vancouver biotech scene? - Business in Vancouver
Norges Bank Buys New Shares in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks (ZYME) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Zymeworks to Engage in Key Investor Conferences - MSN
Zymeworks (ZYME) Is Up 5.2% After First FDA Approval For Zanidatamab And Royalty ShiftHas The Bull Case Changed? - Sahm
Zymeworks (ZYME): Reassessing Valuation After FDA Zanidatamab Approval and a Sharp Share Price Rally - Sahm
Zymeworks Inc Stock Analysis and ForecastPrice Momentum Alerts & Low Entry Investment Plans - earlytimes.in
Zymeworks (ZYME) Price Target Increased by 42.94% to 35.19 - Nasdaq
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):